You have access
The Macrophage Activation Marker Soluble CD163 Predicts the Response to Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma
SOICHI TAKEDA, TADASHI NAMISAKI, ARITOSHI KOIZUMI, HIROAKI TAKAYA, YUKI TSUJI, AKIHIKO SHIBAMOTO, SATOSHI IWAI, TAKASHI INOUE, YUKIHISA FUJINAGA, NORIHISA NISHIMURA, SHINYA SATO, KOH KITAGAWA, KOSUKE KAJI, AKIRA MITORO, KIYOSHI ASADA and HITOSHI YOSHIJI
Anticancer Research October 2025, 45 (10) 4493-4507; DOI: https://doi.org/10.21873/anticanres.17797